BMP4-Expressing Muscle-Derived Stem Cells Differentiate into Osteogenic Lineage and Improve Bone Healing in Immunocompetent Mice
Open Access
- 1 August 2002
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 6 (2), 169-178
- https://doi.org/10.1006/mthe.2002.0654
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Human skeletal muscle cells in ex vivo gene therapy to deliver bone morphogenetic protein-2The Journal of Bone and Joint Surgery, 2002
- Development of an MFG-Based Retroviral Vector System for Secretion of High Levels of Functionally Active Human BMP4Molecular Therapy, 2001
- Exogenously Regulated Stem Cell-Mediated Gene Therapy for Bone RegenerationMolecular Therapy, 2001
- Transient Production of Bone Morphogenetic Protein 2 by Allogeneic Transplanted Transduced Cells Induces Bone FormationHuman Gene Therapy, 2000
- Regional gene therapy with a BMP‐2‐producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodentsJournal of Orthopaedic Research, 1998
- Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic musclesGene Therapy, 1998
- Overexpression of an Osteogenic Morphogen in Fibrodysplasia Ossificans ProgressivaNew England Journal of Medicine, 1996
- Fibrodysplasia (myositis) ossificans progressiva: clinicopathological features and natural historyQJM: An International Journal of Medicine, 1996
- Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage [published erratum appears in J Cell Biol 1995 Feb;128(4):following 713]The Journal of cell biology, 1994
- Genetic aspects of fibrodysplasia ossificans progressiva.Journal of Medical Genetics, 1982